These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


481 related items for PubMed ID: 25542235

  • 1. Curcumin reverses cisplatin resistance in cisplatin-resistant lung caner cells by inhibiting FA/BRCA pathway.
    Chen P, Li J, Jiang HG, Lan T, Chen YC.
    Tumour Biol; 2015 May; 36(5):3591-9. PubMed ID: 25542235
    [Abstract] [Full Text] [Related]

  • 2. RNA interferences targeting the Fanconi anemia/BRCA pathway upstream genes reverse cisplatin resistance in drug-resistant lung cancer cells.
    Dai CH, Li J, Chen P, Jiang HG, Wu M, Chen YC.
    J Biomed Sci; 2015 Sep 18; 22(1):77. PubMed ID: 26385482
    [Abstract] [Full Text] [Related]

  • 3. XPC inhibition rescues cisplatin resistance via the Akt/mTOR signaling pathway in A549/DDP lung adenocarcinoma cells.
    Teng X, Fan XF, Li Q, Liu S, Wu DY, Wang SY, Shi Y, Dong M.
    Oncol Rep; 2019 Mar 18; 41(3):1875-1882. PubMed ID: 30628719
    [Abstract] [Full Text] [Related]

  • 4. Reversal of multidrug resistance by curcumin through FA/BRCA pathway in multiple myeloma cell line MOLP-2/R.
    Xiao H, Xiao Q, Zhang K, Zuo X, Shrestha UK.
    Ann Hematol; 2010 Apr 18; 89(4):399-404. PubMed ID: 19756599
    [Abstract] [Full Text] [Related]

  • 5. Interference with HMGB1 increases the sensitivity to chemotherapy drugs by inhibiting HMGB1-mediated cell autophagy and inducing cell apoptosis.
    Zhang R, Li Y, Wang Z, Chen L, Dong X, Nie X.
    Tumour Biol; 2015 Nov 18; 36(11):8585-92. PubMed ID: 26040768
    [Abstract] [Full Text] [Related]

  • 6. Curcumin reverses cis-platin resistance and promotes human lung adenocarcinoma A549/DDP cell apoptosis through HIF-1α and caspase-3 mechanisms.
    Ye MX, Zhao YL, Li Y, Miao Q, Li ZK, Ren XL, Song LQ, Yin H, Zhang J.
    Phytomedicine; 2012 Jun 15; 19(8-9):779-87. PubMed ID: 22483553
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of microRNA-196a might reverse cisplatin resistance of A549/DDP non-small-cell lung cancer cell line.
    Li JH, Luo N, Zhong MZ, Xiao ZQ, Wang JX, Yao XY, Peng Y, Cao J.
    Tumour Biol; 2016 Feb 15; 37(2):2387-94. PubMed ID: 26376998
    [Abstract] [Full Text] [Related]

  • 8. Combination treatment of FTY720 and cisplatin exhibits enhanced antitumour effects on cisplatin-resistant non-small lung cancer cells.
    Li Y, Hu T, Chen T, Yang T, Ren H, Chen M.
    Oncol Rep; 2018 Feb 15; 39(2):565-572. PubMed ID: 29207165
    [Abstract] [Full Text] [Related]

  • 9. Effects of VBMDMP on the reversal of cisplatin resistance in human lung cancer A549/DDP cells.
    Wang CK, Zhang Y, Zhang ZJ, Qiu QW, Cao JG, He ZM.
    Oncol Rep; 2015 Jan 15; 33(1):372-82. PubMed ID: 25394854
    [Abstract] [Full Text] [Related]

  • 10. [Antiproliferative effect of curcumin combined with cyclophosmide on the growth of human lymphoma cell line HT/CTX with drug resistance and its relation with FA/BRCA pathway].
    Xiao H, Zhang KJ.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug 15; 16(4):804-8. PubMed ID: 18718065
    [Abstract] [Full Text] [Related]

  • 11. Ginsenoside Rd reverses cisplatin resistance in non-small-cell lung cancer A549 cells by downregulating the nuclear factor erythroid 2-related factor 2 pathway.
    Chian S, Zhao Y, Xu M, Yu X, Ke X, Gao R, Yin L.
    Anticancer Drugs; 2019 Sep 15; 30(8):838-845. PubMed ID: 31415285
    [Abstract] [Full Text] [Related]

  • 12. miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET.
    Chen QY, Jiao DM, Wang J, Hu H, Tang X, Chen J, Mou H, Lu W.
    Oncotarget; 2016 Apr 26; 7(17):24510-26. PubMed ID: 27014910
    [Abstract] [Full Text] [Related]

  • 13. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway.
    Shi H, Pu J, Zhou XL, Ning YY, Bai C.
    Tumour Biol; 2017 May 26; 39(5):1010428317697568. PubMed ID: 28459375
    [Abstract] [Full Text] [Related]

  • 14. siRNA silencing EZH2 reverses cisplatin-resistance of human non-small cell lung and gastric cancer cells.
    Zhou W, Wang J, Man WY, Zhang QW, Xu WG.
    Asian Pac J Cancer Prev; 2015 May 26; 16(6):2425-30. PubMed ID: 25824776
    [Abstract] [Full Text] [Related]

  • 15. Reversal of cisplatin resistance by inhibiting PI3K/Akt signal pathway in human lung cancer cells.
    Zhang Y, Bao C, Mu Q, Chen J, Wang J, Mi Y, Sayari AJ, Chen Y, Guo M.
    Neoplasma; 2016 May 26; 63(3):362-70. PubMed ID: 26925782
    [Abstract] [Full Text] [Related]

  • 16. GLIPR1 modulates the response of cisplatin-resistant human lung cancer cells to cisplatin.
    Gong X, Liu J, Zhang D, Yang D, Min Z, Wen X, Wang G, Li H, Song Y, Bai C, Li J, Zhou J.
    PLoS One; 2017 May 26; 12(8):e0182410. PubMed ID: 28771580
    [Abstract] [Full Text] [Related]

  • 17. [Reversal of multidrug resistance of the drug resistant human multiple myeloma cell line MOLP-2/R by curcumin and its relation with FA/BRCA pathway].
    Xiao H, Zhang KJ, Zuo XL.
    Zhonghua Xue Ye Xue Za Zhi; 2009 Jan 26; 30(1):33-7. PubMed ID: 19563033
    [Abstract] [Full Text] [Related]

  • 18. β-elemene reverses the drug resistance of lung cancer A549/DDP cells via the mitochondrial apoptosis pathway.
    Yao CC, Tu YR, Jiang J, Ye SF, Du HX, Zhang Y.
    Oncol Rep; 2014 May 26; 31(5):2131-8. PubMed ID: 24627125
    [Abstract] [Full Text] [Related]

  • 19. LncRNA SNHG14 regulates the DDP-resistance of non-small cell lung cancer cell through miR-133a/HOXB13 pathway.
    Xu L, Xu Y, Yang M, Li J, Xu F, Chen BL.
    BMC Pulm Med; 2020 Oct 15; 20(1):266. PubMed ID: 33059643
    [Abstract] [Full Text] [Related]

  • 20. Bisdemethoxycurcumin sensitizes cisplatin-resistant lung cancer cells to chemotherapy by inhibition of CA916798 and PI3K/AKT signaling.
    Wang HJ, Yang ZX, Dai XT, Chen YF, Yang HP, Zhou XD.
    Apoptosis; 2017 Sep 15; 22(9):1157-1168. PubMed ID: 28677094
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 25.